Rogelio Sandoval has served as our Chief Financial Officer since August 2015. He has over 19 years of broad-based domestic and international experience at pharmaceutical companies with significant operation scale, especially in Latin America.

Mr. Sandoval joins moksha8 from UCB the global biopharmaceutical focused on neurological and immunological diseases. Under his nine-year tenure he held several finance and operations positions, being Director, Finance Business Partner Latam Operations the last.

Before UCB, Mr. Sandoval held various progressive finance positions at Teva, IVAX Pharmaceuticals and Revlon, where he started his professional career. He received his BA in Accounting from UNITEC University.